This content is from: Trademarks

Managing IP’s most-read stories in April 2019

The tragic death of an IP lawyer, a US Supreme Court case on scandalous trademarks and changes to China’s foreign investment rules were among the most popular stories in April

top51.     “Approachable and instrumental”: Baker McKenzie’s global chair, Paul Rawlinson, passes away

The most-read story of the month was our tribute to Paul Rawlinson, the former global chair of Baker McKenzie who passed away unexpectedly on April 12. Paul was remembered as approachable and instrumental in Baker McKenzie’s work.

2.       Scandalous TM case may not follow Tam, as many predicted

Also popular this month was our story on the scandalous trademark case being heard at the US Supreme Court. We spoke to experts who are following the case, with some suggesting that the line of questioning suggests that a reversal may be possible.

3.       China clears licensing obstacles for foreign investment

Third on the list is an update on China, where the new Technology Import/Export Regulations have been applauded by businesses. However, as we found out, foreign companies still need to be mindful of the recordal process for licensing agreements.

4.       Life after GDPR: the trials and tribulations of domain name enforcement

The much-discussed issue of GDPR came fourth, as lawyers from Adobe, Amazon and others discussed the challenges for brands seeking to enforce their trademark rights in domain names. It’s nearly a year since the EU implemented the regulation.

5.       World IP Day 2019: The athletes and football clubs that dominate trademarks

Finally, readers enjoyed our piece on World IP Day, on April 26, the theme of which was “Reach For Gold: IP and Sports”. We examined the different ways in which IP affects sport, including how Usain Bolt and Manchester United make use of trademarks.

The material on this site is for law firms, companies and other IP specialists. It is for information only. Please read our Terms and Conditions and Privacy Notice before using the site. All material subject to strictly enforced copyright laws.

© 2021 Euromoney Institutional Investor PLC. For help please see our FAQs.


Instant access to all of our content. Membership Options | 30 Day Trial